FMS vs LH
Fresenius Medical Care AG and Labcorp Holdings Inc., side by side — 7 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | FMS | LH |
|---|---|---|
| Revenue | $14.6B | $14.0B |
| Net income | $1.1B | $876.5M |
| Gross margin | 32.4% | 28.8% |
| Net margin | 8.6% | 6.3% |
| Return on equity | 12.2% | 10.5% |
| Diluted EPS | $3.65 | $10.46 |
| Dividend / share | — | $2.88 |
| Payout ratio | 26.7% | 27.5% |
| Free cash flow | $1.3B | $1.2B |
| Equity | $9.2B | $8.6B |
| Net debt / equity | 0.78× | 0.59× |
| Current ratio | 1.77× | 1.42× |
| Revenue CAGR 5y | 6.6% | −0.0% |
| Profit CAGR 5y | 6.3% | −10.8% |
FMS and LH book revenue within 15% of each other, and keeps more of each dollar of revenue as profit (8.6% against 6.3%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Revenue by year
7 years side by side
| Fiscal year | FMS | LH |
|---|---|---|
| FY2013 | $14.6B | $5.8B |
| FY2012 | $13.8B | $5.7B |
| FY2011 | $12.6B | $5.5B |
| FY2010 | $11.8B | $5.0B |
| FY2009 | $11.2B | $4.7B |
| FY2008 | $10.6B | $4.5B |
| FY2007 | $9.7B | $4.1B |
Net income by year
Bottom line
| Fiscal year | FMS | LH |
|---|---|---|
| FY2013 | $1.1B | $573.8M |
| FY2012 | $1.2B | $583.1M |
| FY2011 | $1.1B | $519.7M |
| FY2010 | $978.5M | $558.2M |
| FY2009 | $891.1M | $543.3M |
| FY2008 | $817.6M | $464.5M |
| FY2007 | $717.1M | $476.8M |